| Date Filed | Type | Description |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/18/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 11/14/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 11/04/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 11/03/2016 |
SC 13D/A
| Tobira Therapeutics, Inc. has filed a Schedule 13D for Tobira Therapeutics, Inc. |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 11/03/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 11/02/2016 |
SC 13D/A
| Allergan plc reports a 100% stake in Tobira Therapeutics, Inc. |
| 11/01/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 11/01/2016 |
8-K
| Quarterly results |
| 11/01/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 10/19/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 10/14/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 10/04/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 10/03/2016 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 10/03/2016 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 09/23/2016 |
SC 13G
| STONEPINE CAPITAL, L.P. reports a 4.3% stake in Tobira Therapeutics, Inc. |
| 09/22/2016 |
SC 13G/A
| Tobira Therapeutics, Inc. reports a 2.1% stake in Tobira Therapeutics, Inc. |
| 09/22/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 09/21/2016 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 09/20/2016 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
| 09/20/2016 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 09/20/2016 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...|
Docs:
|
"Agreement and Plan of Merger, by and among Allergan Holdco US, Inc., Sapphire Acquisition Corp. and Tobira Therapeutics, Inc",
"Tender and Support Agreement, by and among Allergan Holdco US, Inc., Sapphire Acquisition Corp. and certain directors and stockholders of Tobira Therapeutics, Inc",
"Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH" |
|
| 09/09/2016 |
10-Q/A
| Quarterly Report for the period ended March 31, 2016 [amend] |
| 09/01/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 08/10/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 08/09/2016 |
10-Q
| Quarterly Report for the period ended June 30, 2016 |
| 08/09/2016 |
8-K
| Form 8-K - Current report |
| 07/25/2016 |
8-K
| Form 8-K - Current report |
|